LobbyingSanofi U.S. lobbying by quarter
Sanofi U.S. SNY's latest lobbying report covers Q2 2026, at $100K. The four quarters Q4 2025–Q3 2026 total $300K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Sanofi U.S.SNY
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $300K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $100K | 2 |
| Q1 2023 | $100K | 2 |
| Q2 2023 | $100K | 2 |
| Q3 2023 | $100K | 2 |
| Q4 2023 | $100K | 2 |
| Q1 2024 | $100K | 2 |
| Q2 2024 | $100K | 2 |
| Q3 2024 | $100K | 2 |
| Q4 2024 | $100K | 2 |
| Q1 2025 | $100K | 2 |
| Q2 2025 | $100K | 2 |
| Q3 2025 | $100K | 2 |
| Q4 2025 | $100K | 2 |
| Q1 2026 | $100K | 2 |
| Q2 2026 | $100K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$383.3K · 30 reports
- Medicare and Medicaid$383.3K · 30 reports
- Taxation$383.3K · 30 reports
- Budget and appropriations$150K · 15 reports
- Medical research and clinical labs$150K · 15 reports
- Defense$50K · 4 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES30 reports
- SENATE30 reports
Firms it paid
| Firm | ||
|---|---|---|
| Forbes-Tate | $750K | 15 quarters |
| Williams and Jensen, PLLC | $750K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| CHRISTOPHER E. WILCOX | LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings | Q2 2026 |
| JEANNE HAGGERTY | Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member | Q2 2026 |
| ROBERT BUTORA | Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess | Q2 2026 |
| KURT SCHRADER | Former Member of Congress | Q4 2025 |
| ALEC ARAMANDA | Deputy Legislative Director, Leg Asst, Sen. Cruz; Leg Asst, Sen. DeMint. | Q4 2024 |
| CHRISTOPHER W HATCHER | Sch. C, Treasury; Associate Staff, House Rules Committee; LD, Rep. Scott McInnis | Q4 2024 |
| KARINA LYNCH | Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs | Q3 2024 |
| DANIEL ZIEGLER | Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn | Q3 2023 |
| CHERYL LYNN JAEGER | Shd employee, Ofc of the Speaker 7 Ofc of VA 7; Sr. Policy Adv, Maj Leader, Rep Cantor; Sr. Policy Adv, Rep Whip, Rep Cantor; Sr. Policy Adv, Maj Whip, Rep Blunt; Prof Staff House Committee on E&C; Sr LA to Rep C. Cox | Q1 2023 |
| SUSAN HIRSCHMANN | COS, Rep. Van Hilleary and Majority Whip Tom DeLay | Q1 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Forbes-Tate | $50K |
| 07/20for Q2 | Williams and Jensen, PLLC | $50K |
| 04/20for Q1 | Williams and Jensen, PLLC | $50K |
| 04/19for Q1 | Forbes-Tate | $50K |
| 01/20for Q4 2025 | Williams and Jensen, PLLC | $50K |
| 01/17for Q4 2025 | Forbes-Tate | $50K |
| 25/10/20for Q3 2025 | Williams and Jensen, PLLC | $50K |
| 25/10/18for Q3 2025 | Forbes-Tate | $50K |
| 25/07/21for Q2 2025 | Williams and Jensen, PLLC | $50K |
| 25/07/17for Q2 2025 | Forbes-Tate | $50K |
| 25/04/21for Q1 2025 | Williams and Jensen, PLLC | $50K |
| 25/04/16for Q1 2025 | Forbes-Tate | $50K |
| 25/01/22for Q4 2024 | Williams and Jensen, PLLC | $50K |
| 25/01/19for Q4 2024 | Forbes-Tate | $50K |
| 24/10/18for Q3 2024 | Williams and Jensen, PLLC | $50K |
| 24/10/17for Q3 2024 | Forbes-Tate | $50K |
| 24/07/19for Q2 2024 | Williams and Jensen, PLLC | $50K |
| 24/07/13for Q2 2024 | Forbes-Tate | $50K |
| 24/04/19for Q1 2024 | Williams and Jensen, PLLC | $50K |
| 24/04/12for Q1 2024 | Forbes-Tate | $50K |